Ketamine for Bipolar Depression

Find clinics offering ketamine therapy for bipolar disorder (depressive phase).

Reviewed for clinical accuracy against peer-reviewed literature and FDA guidelines · Last reviewed March 2026

🌑 Ketamine Therapy for Bipolar Depression: What You Need to Know

Bipolar depression — the depressive phase of bipolar disorder — is one of the most challenging psychiatric conditions to treat. Patients with bipolar disorder spend significantly more time in depressive episodes than in manic or hypomanic states, and bipolar depression is associated with higher rates of disability, hospitalization, and suicide compared to unipolar depression. Traditional antidepressants are often ineffective for bipolar depression and may carry the risk of triggering manic or hypomanic episodes.

Ketamine has shown significant promise for bipolar depression, with research demonstrating rapid antidepressant effects similar to those seen in unipolar treatment-resistant depression. The critical distinction is that ketamine for bipolar depression must be administered with careful psychiatric oversight, with patients maintained on an established mood stabilizer (such as lithium or valproate) throughout treatment.

Importantly, current evidence suggests that ketamine at sub-anesthetic doses does not trigger mania, making it a relatively safe option for bipolar patients when proper protocols are followed. This is a meaningful advantage over traditional antidepressants, many of which carry significant mania risk in bipolar patients. Ketamine clinics offering bipolar depression treatment typically require documentation of a stable mood stabilizer regimen before initiating therapy.

How Ketamine Works for Bipolar Depression

Ketamine's mechanism of action in bipolar depression mirrors its effects in unipolar depression: NMDA receptor antagonism leads to increased glutamate release, AMPA receptor activation, BDNF production, and rapid synaptogenesis in the prefrontal cortex. These effects restore neural connectivity that has been impaired during depressive episodes.

Critically, at the sub-anesthetic doses used in clinical ketamine treatment (typically 0.5 mg/kg IV over 40 minutes), research has not found evidence that ketamine triggers manic or hypomanic switching. This may be because ketamine's effects are mediated through glutamate rather than monoamine systems (serotonin, norepinephrine, dopamine), which are more closely linked to manic switching. However, careful monitoring remains essential, and treatment is always administered with a mood stabilizer already in place to provide an additional safety net.

Clinical Evidence

A landmark study by Diazgranados et al. (2010) at the National Institute of Mental Health demonstrated that a single IV ketamine infusion produced rapid and robust antidepressant effects in patients with bipolar depression who were maintained on therapeutic doses of lithium or valproate. The antidepressant response emerged within 40 minutes of the infusion. Subsequent studies have confirmed these findings, and importantly, none of the controlled trials of ketamine in bipolar depression have reported treatment-emergent mania or hypomania. However, patients must be on a stable mood stabilizer regimen, as ketamine has not been studied as a monotherapy for bipolar depression.

Who Is a Candidate?

Candidates for ketamine therapy for bipolar depression include patients with Bipolar I or Bipolar II disorder who are currently in a depressive episode, are maintained on a stable mood stabilizer (lithium, valproate, lamotrigine, or an atypical antipsychotic), and have failed to respond adequately to multiple antidepressant and mood stabilizer combinations. Patients must not be in a current manic, hypomanic, or mixed episode. A thorough psychiatric evaluation confirming the bipolar diagnosis and current mood state is required before treatment. Patients with rapid-cycling bipolar disorder may require additional monitoring.

Side Effects to Consider

Side effects of ketamine for bipolar depression are similar to those in unipolar depression treatment: dissociation, dizziness, nausea, and transient blood pressure elevation. For bipolar patients specifically, the primary concern is the theoretical risk of precipitating mania or hypomania, though this has not been observed in controlled clinical trials at standard sub-anesthetic doses. Bipolar patients receiving ketamine should be monitored for any signs of mood elevation or activation both during and in the days following treatment. All patients must continue their mood stabilizer regimen throughout the course of ketamine therapy.

Frequently Asked Questions

Common questions about ketamine therapy for bipolar disorder (depressive phase).

Is ketamine safe for bipolar disorder?

Clinical evidence to date indicates that ketamine is safe for bipolar depression when administered at sub-anesthetic doses to patients who are maintained on a stable mood stabilizer. Controlled trials, including the landmark study by Diazgranados et al. (2010) at the National Institute of Mental Health and subsequent replication studies, have not reported treatment-emergent mania or hypomania in patients receiving ketamine while on therapeutic doses of lithium or valproate. This favorable safety profile may be because ketamine acts through the glutamate system rather than the monoamine pathways more closely linked to manic switching. However, it is essential that ketamine for bipolar depression is always administered under careful psychiatric supervision, with the patient continuously maintained on their mood stabilizer throughout the entire course of ketamine treatment. Ketamine has not been studied as monotherapy for bipolar depression and should never be used without a mood stabilizer in place. Inform your treating psychiatrist about all medications you are taking before beginning ketamine therapy.

Can ketamine trigger mania?

Controlled clinical trials of ketamine at the standard sub-anesthetic dose of 0.5 mg/kg IV in bipolar patients maintained on mood stabilizers have not observed treatment-emergent mania or hypomania. The studies by Diazgranados et al. (2010) and Zarate et al. (2012) both confirmed this safety finding, and a 2021 systematic review by Bahji et al. in the International Journal of Neuropsychopharmacology reported an acceptable short-term safety profile for ketamine in bipolar depression. However, this does not mean the risk is zero, and patients should be monitored closely for any signs of mood elevation, increased energy, reduced need for sleep, or racing thoughts both during and in the days following treatment. Ketamine should never be used as monotherapy for bipolar depression without a mood stabilizer in place, as it has not been studied in that context. Report any mood changes to your prescribing psychiatrist immediately so your treatment plan can be adjusted if necessary.

Does ketamine work for bipolar depression?

Yes, research demonstrates that ketamine produces rapid antidepressant effects in bipolar depression similar to those seen in unipolar treatment-resistant depression. The landmark study by Diazgranados et al. (2010) at the National Institute of Mental Health showed significant improvement within 40 minutes of a single infusion in patients maintained on therapeutic doses of lithium or valproate, and this finding was subsequently replicated by Zarate et al. (2012). Ketamine may be particularly valuable for bipolar depression because many traditional antidepressants are either ineffective for this condition or carry the risk of triggering manic or hypomanic episodes, limiting treatment options considerably. Patients with bipolar disorder spend significantly more time in depressive episodes than in elevated mood states, making effective depression treatment critical for overall quality of life. The key requirement is that ketamine must always be administered as an add-on to an established mood stabilizer regimen. Discuss this option with your psychiatrist to determine whether you are an appropriate candidate.

What precautions are needed for ketamine with bipolar disorder?

Several important precautions must be followed when using ketamine for bipolar depression to ensure safe and effective treatment. First, maintaining a therapeutic dose of a mood stabilizer — lithium, valproate, lamotrigine, or an atypical antipsychotic — throughout the entire ketamine treatment course is mandatory, as all clinical trials including Diazgranados et al. (2010) required concurrent mood stabilization. Second, the patient must not be currently in a manic, hypomanic, or mixed episode, as ketamine has only been studied during the depressive phase. Third, close monitoring for any signs of mood switching is essential both during infusion sessions and in the days following treatment — watch for increased energy, reduced sleep need, or racing thoughts. Fourth, regular psychiatric follow-up should be maintained throughout the treatment course. Patients should always inform their prescribing psychiatrist about ketamine treatment so all providers can coordinate care effectively and monitor for mood changes between sessions.

References

  1. Diazgranados N et al. (2010) Arch Gen Psychiatry. First RCT demonstrating a single ketamine infusion as add-on to mood stabilizer produced rapid antidepressant response in treatment-resistant bipolar depression. [DOI]
  2. Zarate CA Jr et al. (2012) Biol Psychiatry. Replication study confirmed ketamine's rapid antidepressant efficacy as an adjunct to lithium or valproate in bipolar depression. [DOI]
  3. Bahji A et al. (2021) Int J Neuropsychopharmacol. Systematic review found ketamine demonstrated rapid but transient antidepressant effects in bipolar depression with an acceptable short-term safety profile. [DOI]
Treatment Options

Treatment Types for Bipolar Depression

Explore the different ways ketamine therapy can be administered for bipolar disorder (depressive phase).

IV Ketamine Infusion

Intravenous delivery. Fastest onset, 60-70% response rate. $400-800/session.

Spravato (Esketamine)

FDA-approved nasal spray. Often insurance-covered. $590-885/session.

IM Injection

Intramuscular injection. Similar efficacy, lower cost. $250-500/session.

KAP (Ketamine-Assisted Psychotherapy)

Combines ketamine with guided psychotherapy. $500-1,500/session.
Browse by State

Ketamine for Bipolar Depression — Clinics by State

Alabama 37 clinics → Alaska 10 clinics → Arizona 115 clinics → Arkansas 53 clinics → California 336 clinics → Colorado 71 clinics → Connecticut 65 clinics → Delaware 12 clinics → District of Columbia 4 clinics → Florida 218 clinics → Georgia 62 clinics → Hawaii 5 clinics → Idaho 30 clinics → Illinois 139 clinics → Indiana 72 clinics → Iowa 62 clinics → Kansas 68 clinics → Kentucky 63 clinics → Louisiana 57 clinics → Maine 14 clinics → Maryland 86 clinics → Massachusetts 96 clinics → Michigan 80 clinics → Minnesota 47 clinics → Mississippi 26 clinics → Missouri 68 clinics → Montana 22 clinics → Nebraska 55 clinics → Nevada 42 clinics → New Hampshire 16 clinics → New Jersey 113 clinics → New Mexico 16 clinics → New York 199 clinics → North Carolina 113 clinics → North Dakota 5 clinics → Ohio 119 clinics → Oklahoma 59 clinics → Oregon 47 clinics → Pennsylvania 81 clinics → Rhode Island 12 clinics → South Carolina 36 clinics → South Dakota 9 clinics → Tennessee 87 clinics → Texas 325 clinics → Utah 90 clinics → Vermont 9 clinics → Virginia 102 clinics → Washington 86 clinics → West Virginia 27 clinics → Wisconsin 34 clinics → Wyoming 6 clinics →